We are live on ! Find out more
Schroder Investment Management Group

Schroder Investment Management Group Portfolio holdings

AUM $141B
1-Year Est. Return 34.18%
This Fund
S&P 500
This Quarter Est. Return
-2.16%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+619.19%
AUM
$99.1B
AUM Growth
-$5.32B
Cap. Flow
-$740M
Cap. Flow %
-0.75%
Top 10 Hldgs %
27.72%
Holding
1,277
New
83
Increased
445
Reduced
587
Closed
91

Top Buys

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$927M
2
AVGO icon
Broadcom
AVGO
+$406M
3
BLK icon
Blackrock
BLK
+$362M
4
CARR icon
Carrier Global
CARR
+$224M
5
LRCX icon
Lam Research
LRCX
+$172M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$325M
2
TSLA icon
Tesla
TSLA
+$304M
3
GEV icon
GE Vernova
GEV
+$283M
4
NVDA icon
NVIDIA
NVDA
+$280M
5
ZBRA icon
Zebra Technologies
ZBRA
+$277M

Sector Composition

Rank Sector Weight
1 Technology 26.33%
2 Financials 13.48%
3 Communication Services 12.67%
4 Consumer Discretionary 12.01%
5 Healthcare 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
801
ADMA Biologics
ADMA
$2.11B
$3.58M ﹤0.01%
+176,482
New +$3.05M
ALHC icon
802
Alignment Healthcare
ALHC
$2.79B
$3.53M ﹤0.01%
+192,849
New +$2.88M
KEYS icon
803
Keysight
KEYS
$60.5B
$3.46M ﹤0.01%
23,018
-3,587
-13% -$592K
RNAM
804
DELISTED
Avidity Biosciences
RNAM
$3.44M ﹤0.01%
109,003
+47,523
+77% +$1.48M
BAH icon
805
Booz Allen Hamilton
BAH
$9.43B
$3.43M ﹤0.01%
113,897
+109,644
+2,578% +$13.2M
ZLAB icon
806
Zai Lab
ZLAB
$2.92B
$3.41M ﹤0.01%
91,504
– –
URGN icon
807
UroGen Pharma
URGN
$2.34B
$3.4M ﹤0.01%
+303,397
New +$3.23M
MAA icon
808
Mid-America Apartment Communities
MAA
$15.6B
$3.39M ﹤0.01%
20,440
+3,828
+23% +$606K
GLW icon
809
Corning
GLW
$137B
$3.39M ﹤0.01%
74,042
-15,343
-17% -$758K
XYL icon
810
Xylem
XYL
$28.1B
$3.36M ﹤0.01%
28,150
-511
-2% -$63.3K
MCHP icon
811
Microchip Technology
MCHP
$42.2B
$3.36M ﹤0.01%
68,945
-552,219
-89% -$30.8M
EWC icon
812
iShares MSCI Canada ETF
EWC
$6.55B
$3.31M ﹤0.01%
81,708
-76,263
-48% -$3.13M
NBIX icon
813
Neurocrine Biosciences
NBIX
$15.3B
$3.29M ﹤0.01%
29,735
-97,000
-77% -$12.3M
IR icon
814
Ingersoll Rand
IR
$32.7B
$3.27M ﹤0.01%
41,165
+6,791
+20% +$592K
ADM icon
815
Archer Daniels Midland
ADM
$38.6B
$3.24M ﹤0.01%
67,757
-331
-0.5% -$16K
HUM icon
816
Humana
HUM
$46.2B
$3.23M ﹤0.01%
12,220
-18,662
-60% -$5.05M
MLM icon
817
Martin Marietta Materials
MLM
$32.7B
$3.22M ﹤0.01%
6,734
– –
DBX icon
818
Dropbox
DBX
$7.81B
$3.18M ﹤0.01%
119,789
-427,051
-78% -$12.4M
PCG icon
819
PG&E
PCG
$38.5B
$3.16M ﹤0.01%
183,920
-20,605
-10% -$342K
CBOE icon
820
Cboe Global Markets
CBOE
$30.6B
$3.14M ﹤0.01%
14,123
+8,749
+163% +$1.81M
RCKT icon
821
Rocket Pharmaceuticals
RCKT
$367M
$3.14M ﹤0.01%
413,550
– –
VNDA icon
822
Vanda Pharmaceuticals
VNDA
$304M
$3.13M ﹤0.01%
666,461
-371,559
-36% -$1.73M
BNDX icon
823
Vanguard Total International Bond ETF
BNDX
$83B
$3.12M ﹤0.01%
63,916
-303
-0.5% -$14.8K
FOLD
824
DELISTED
Amicus Therapeutics
FOLD
$3.11M ﹤0.01%
369,013
– –
CHH icon
825
Choice Hotels
CHH
$4.71B
$3.1M ﹤0.01%
+23,596
New +$3.36M
31 32
33
34 35

Similar funds

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group's Q1 2025 Portfolio in Review

As of Q1 2025, Schroder Investment Management Group held 1,277 positions worth $99.1B, down 5.1% from $104B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Schroder Investment Management Group's Q1 2025 filing shows 83 new, 445 increased, 587 reduced and 91 closed positions. Its largest new stake was Arista Networks: 9,143,531 shares worth $708M. The largest sale was Merck, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Financials and Communication Services.

  • Schroder Investment Management Group's largest Q1 2025 buy was Arista Networks: 9,143,531 shares worth $708M.
  • Schroder Investment Management Group added most to Broadcom in Q1 2025, an estimated $406M increase.
  • Schroder Investment Management Group's biggest Q1 2025 reduction was Merck, cutting an estimated $325M.
  • Schroder Investment Management Group fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $62M.
  • Schroder Investment Management Group's ten largest holdings make up 28% of its $99.1B portfolio in Q1 2025.
  • Schroder Investment Management Group opened 83 new positions and closed 91 in Q1 2025.
  • Schroder Investment Management Group's portfolio value fell 5.1% quarter-over-quarter to $99.1B.

Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.